Chronic News and Research

RSS

Children's National receives new funding to strengthen global polycystic kidney disease initiative

Lisa M. Guay-Woodford, M.D., McGehee Joyce Professor of Pediatrics at Children's National Hospital, has received a $5.7 million dollar gift to support clinical and research activities.

13 Nov 2019

Tall people more likely to develop atrial fibrillation

Size may matter when it comes to having a safe and steady heart. A new study shows tall people are more likely to develop from an irregular heartbeat, known as atrial fibrillation (AFib).

13 Nov 2019

The arts could benefit health finds landmark WHO report

The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.

13 Nov 2019

Study uncovers risk factors associated with postpartum opioid overdose

Massachusetts researchers have published a new study in the journal Addiction that uncovers several risk factors associated with postpartum opioid overdose.

13 Nov 2019

Study offers significant contribution for recovery of motor functions

Delivering a diversified electric message to the different fibres of the injured spinal cord through a new technology able to deliver it in a targeted and independent manner. What is the result? Greater efficiency in recovering the control of voluntary limb movements in the event of serious damage to the spinal cord.

13 Nov 2019

Researchers use phage therapy to successfully treat alcoholic liver disease

Researchers have successfully used bacteriophage (phage) therapy to eliminate alcohol-related liver disease in an animal model.

13 Nov 2019

Stress affects circadian rhythm, increases metabolic disease risk

Stress is a normal part of life, but too much of everything isn’t healthy. Every day, people from all walks of life experience stress of various degrees. A new study found that when stress has disrupted the circadian rhythm, the body’s internal clock, it can increase the risk of developing metabolic diseases.

12 Nov 2019

Medical steroid use could push up diabetes risk

Glucocorticoids (GCs), or steroids, as they are popularly called, are often prescribed for their anti-inflammatory effects in a host of conditions including acute asthmatic attacks, allergies, and arthritis. However, are they doing good or harm?

12 Nov 2019

Study could open new avenues for antibacterial treatments

Scientists have revealed how common respiratory bugs that cause serious infections in people with cystic fibrosis interact together, according to a new study in eLife.

12 Nov 2019

Chronic psychosocial adversity impairs dopamine production

People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.

12 Nov 2019

Depression in middle and older adulthood associated with nutrition

Your diet can put you at risk of depression, according to a new study. The study also found that the likelihood of depression is higher among middle-aged and older women who were immigrants to Canada when compared to Canadian-born women.

12 Nov 2019

Two strains of the same bacterium work together to cause deadly flesh-eating disease

Two different strains of the same flesh-eating bacteria species work in combination to become more dangerous.

12 Nov 2019

Some academics quietly take side jobs helping tobacco companies in court

In 1998, major tobacco companies reached a historic legal settlement with states that had sued them over the health care costs of smoking-related illnesses.

12 Nov 2019

Polygenic risk score improves psychosis risk prediction, study finds

A new study led by researchers at the University of North Carolina at Chapel Hill has found that that using a polygenic risk score based on data from genome-wide association studies improves psychosis risk prediction in persons meeting clinical high-risk criteria.

12 Nov 2019

Researchers propose new criteria for diagnosing COPD

Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.

12 Nov 2019

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.

11 Nov 2019

Women with gestational hypertension have elevated cardiovascular risk later in life

Research published online today in Journal of the American College of Cardiology, confirms that women who have gestational hypertension or preeclampsia in at least one pregnancy will have higher cardiovascular risk than women without such a history, and that this elevated risk persists at least into their 60s.

11 Nov 2019

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Pemphigus, an autoimmune disease mediated by B cells and which causes painful blisters and sores on the skin and mucous membranes, is a rare chronic autoimmune condition that can be fatal if not treated.

11 Nov 2019

Age of psoriasis onset decides if the skin or joints act up first

People with psoriatic arthritis may initially present with either psoriasis or arthritis as the first symptom/sign of this illness. Now, a new study presented at the 2019 ACR/ARP Annual Meeting shows that the age at which psoriasis develops is a key predictor of which shows up first. Early-onset psoriasis is not strongly associated with arthritis while late-onset psoriasis is.

11 Nov 2019

Rheumatoid arthritis: biologics useful in young and old alike

A new study presented at the 2019 ACR/ARP Annual Meeting says that all rheumatoid arthritis (RA) patients, irrespective of their age, benefit to a similar extent from the use of biologic drugs in their treatment. The study measured improvement in disease parameters 48 weeks after the beginning of therapy to establish this conclusion.

11 Nov 2019